Title

Quiroz Selected for ARPA-H Project Targeting the Origins of Neurodegenerative Disease

Subhead
The Coulter BME researcher will help build a large-scale library of disordered protein regions to uncover new therapeutic targets.
ID
Nov 17, 2026 | By Benjamin Hosking
News Image
Coulter BME Assistant Professor Felipe Quiroz, a researcher on the ARPA-H-funded NATIVE-ID project.
Widgets

Coulter BME Asst. Prof. Felipe Quiroz is part of a major multi-institutional effort that seeks to decode how disordered proteins contribute to neurodegenerative disease and use that knowledge to identify new paths toward prevention and treatment. The Advanced Research Projects Agency for Health (ARPA-H) has awarded the team up to $28.6 million over the next two years through its BIOGAMI program.

Most neurodegenerative diseases begin with clumping of disordered proteins. While AI tools like the Nobel Prize–winning AlphaFold2 have revolutionized protein science, all current AI models have a key limitation: they can only predict the structured portions of proteins. Yet well over fifty percent of human proteins have at least one large intrinsically disordered protein region (IDR) that does not adopt a fixed three-dimensional structure. Mutations in these regions are known to cause proteins to clump together or misfold in ways that damage cells, ultimately leading to multiple diseases such as Alzheimer’s disease, amyotrophic lateral sclerosis and Parkinson’s disease. 

The newly funded project, called NATIVE-ID (Native-context Analysis and Therapeutic Intervention for Variant Ensembles in Intrinsically Disordered proteins), will study diverse IDRs and human IDR variants in live, disease-relevant intracellular contexts at AI-relevant scales.

While research into the function of IDRs has grown in the last decade, current methods remain inadequate to address why the same IDRs cause proteins to aggregate in one patient but not another or why environmental stressors are linked to IDR aggregation and neurodegeneration. The overall BIOGAMI program’s goal is to transform our understanding of protein dysfunction in the earliest stages of neurodegenerative disease by developing new approaches to detect and characterize protein misfolding in genomically and physiologically precise cell models. BIOGAMI is led by ARPA-H Program Manager Shannon Greene, Ph.D.

Quiroz and his team will receive up to $2.4M to fund the creation of the library of IDRs required for this large-scale effort. In parallel, the multi-institutional team will develop a comprehensive machine learning model that integrates a wide range of experimental data, learns to “speak the language” of IDRs, and ultimately predicts the overall pathogenic cascade, from healthy states to misfolding and aggregation, mapping the earliest stages of protein dysfunction known to lead to neurodegeneration. This foundation model and the massive data used to train it will help uncover new therapeutic targets to prevent or treat protein aggregation disorders.

“When the BIOGAMI program launched requesting ideas to solve the IDR puzzle and its link to human neurodegeneration, my colleagues and I immediately got to work. We wanted to contribute our expertise, and we were thrilled by the challenge and opportunity,” says Quiroz, whose research is at the forefront of efforts to control and study IDR clumping in human cells. “Working with ARPA-H was a unique experience. Building on our initial team and plans, they helped us identify synergies with competing projects, with the goal of establishing the most robust team and research approaches. This scientific dialogue between ARPA-H and our evolving team cemented our position to tackle the ambitious goal of the BIOGAMI program,” added Quiroz.

In addition to Quiroz, the project includes an interdisciplinary group of scientists across multiple institutions. Brad Ringeisen from the Innovative Genomics Institute (IGI) at UC Berkeley leads the effort. Additional principal investigators include Hanqin Li, Robert Tjian, Dirk Hockemeyer, and Yun Song at IGI and UC Berkeley, Nicolas Fawzi at Brown University, Thomas Graham at Johns Hopkins University, Mahlon Collins and Nikolai Slavov at Parallel Squared Technology Institute, Randal Halfmann at Stowers Institute for Medical Research, and Jeetain Mittal at Texas A&M University.

————————

This research was funded, in part, by the Advanced Research Projects Agency for Health (ARPA-H). The views and conclusions contained in this document are those of the authors and should not be interpreted as representing the official policies, either expressed or implied, of the U.S. Government.

Media Contact

Contact the BME Communications team to connect with a faculty member or student about academics or research happening in the Wallace H. Coulter Department of Biomedical Engineering.